ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

Examination of the structural basis for antiviral activity, oral pharmacokinetics, and hepatic metabolism among a series of symmetry-based inhibitors of the human immunodeficiency virus (HIV) protease led to the discovery of ABT-538, a promising experimental drug for the therapeutic intervention in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kempf, D J, Marsh, K C, Denissen, J F, McDonald, E, Vasavanonda, S, Flentge, C A, Green, B E, Fino, L, Park, C H, Kong, X P
Formato: Artigo
Idioma:Inglês
Publicado em: 1995
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC42242/
https://ncbi.nlm.nih.gov/pubmed/7708670
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados